Related Experiment Video
Updated: Sep 3, 2025
06:51
Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
Published on: December 9, 2022
4.4K
In vitro Model Systems for Studies Into Retinal Neuroprotection
Yu Zhu1,2, Bowen Cao2,3, Arianna Tolone1
1Cell Death Mechanisms Group, Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany.
Frontiers in Neuroscience
|July 25, 2022
Summary
This review explores in vitro models for retinal neuroprotection, comparing cell cultures, organoids, and explants. These models aid in understanding disease mechanisms and evaluating novel therapies, aligning with animal testing reduction principles.
Area of Science:
- Ophthalmology and Vision Science
- Neuroscience
- Biomedical Engineering
Background:
- Neurodegenerative retinal diseases, particularly inherited forms, represent a significant unmet medical need.
- Effective therapy development requires robust models for understanding disease mechanisms and testing interventions.
- Current in vivo models present ethical and practical challenges, necessitating the exploration of in vitro alternatives.
Purpose of the Study:
- To provide a comprehensive overview of in vitro model systems for studying retinal neuroprotection.
- To compare the advantages and disadvantages of various in vitro methods, considering the 3R principles (refinement, reduction, replacement).
- To evaluate the utility of these models for assessing neuroprotective treatments and drug delivery systems.
Main Methods:
- Review of established and emerging in vitro techniques, including primary retinal cell cultures, cell lines, retinal organoids, organotypic retinal explants, and whole eyeball cultivation.
- Comparative analysis of model systems based on their suitability for disease mechanism studies, therapeutic evaluation, and toxicity testing.
- Discussion of pharmacological agents (e.g., targeting cGMP, PARP, HDAC) and nanoparticle-based drug delivery systems evaluated in vitro.
Main Results:
- Various in vitro models offer distinct advantages and limitations for studying retinal neuroprotection.
- Models range in complexity from simple cell cultures to more physiologically relevant organoids and explants.
- In vitro systems are valuable for screening drug candidates and assessing the efficacy of drug delivery strategies.
Conclusions:
- In vitro models are crucial for advancing retinal neuroprotection therapy development, offering alternatives to animal testing.
- The choice of in vitro model should be tailored to specific experimental goals, such as mechanistic studies or treatment evaluation.
- Combining different in vitro models may be necessary to achieve a comprehensive understanding of therapeutic efficacy and retinal toxicity.
